Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.
about
Antidiuretic hormone regulation in patients with primary nocturnal enuresisArginine Vasopressin and Copeptin in PerinatologyG-Protein-coupled receptors as potential drug candidates in preeclampsia: targeting the relaxin/insulin-like family peptide receptor 1 for treatment and preventionUrine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart FailurePostoperative care following pituitary surgery.Association of HPA axis hormones with copeptin after psychological stress differs by sexControl of the renal medullary circulation by vasopressin V1 and V2 receptors in the rat.A novel AVP gene mutation in a Turkish family with neurohypophyseal diabetes insipidus.The predictive value of stable precursor fragments of vasoactive peptides in patients with chronic heart failure: data from the GISSI-heart failure (GISSI-HF) trial.Haemodynamic changes caused by alteration of autonomic activity in patients with heart failure.Copeptin levels remain unchanged during the menstrual cycle.Opioid antagonist diprenorphine microinjected into parabrachial nucleus selectively inhibits vasopressin response to hypovolemic stimuli in the rat.Hyponatremia and hypernatremia. A systematic approach to causes and their correction.The clinical physiology of water metabolism. Part I: The physiologic regulation of arginine vasopressin secretion and thirst.Circulating levels of copeptin predict outcome in patients with pulmonary arterial hypertension.A copeptin-based classification of the osmoregulatory defects in the syndrome of inappropriate antidiuresisRole of plasma vasopressin in impaired water excretion of glucocorticoid deficiencyCopeptin as a marker of relative arginine vasopressin deficiency after pediatric cardiac surgery.Intraoperative changes in blood pressure, heart rate, plasma vasopressin, and urinary noradrenalin during elective ovariohysterectomy in dogs: repeatability at removal of the 1st and 2nd ovary.Effectiveness of ibopamine in the management of ascitic liver cirrhosis--a controlled study v placebo and frusemide.The posterior pituitary and diabetes insipidusEffect of arginine vasopressin on renal medullary blood flow. A videomicroscopic study in the ratHuman platelet fraction arginine-vasopressin. Potential physiological role.Changes in the metabolic clearance of vasopressin and in plasma vasopressinase throughout human pregnancy.Role of volume in the regulation of vasopressin secretion during pregnancy in the ratHereditary central diabetes insipidus: plasma levels of antidiuretic hormone in a family with a possible osmoreceptor defect.Iatrogenic hyponatraemia of the newborn due to maternal fluid overload: a prospective study.Concentrations of the stress hormone copeptin increase upon hypoglycaemia in patients with type 1 diabetes dependent of hypoglycaemia awarenessDistribution, blood transport, and degradation of antidiuretic hormone in man.The water deprivation test and a potential role for the arginine vasopressin precursor copeptin to differentiate diabetes insipidus from primary polydipsiaCopeptin testing in acute myocardial infarction: ready for routine use?Copeptin and risk stratification in patients with acute dyspnea.Copeptin is associated with kidney length, renal function, and prevalence of simple cysts in a population-based study.Identification of 13 new mutations in the vasopressin-neurophysin II gene in 17 kindreds with familial autosomal dominant neurohypophyseal diabetes insipidusCopeptin Predicts Mortality in Critically Ill Patients.Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: results from the CRISP cohortIncreased thirst and plasma arginine vasopressin levels during 2-deoxy-D-glucose-induced glucoprivation in humans.Vasopressin function in familial cranial diabetes insipidusVascular effects of arginine vasopressin during fluid deprivation in the rat.Osmoregulation during pregnancy in the rat. Evidence for resetting of the threshold for vasopressin secretion during gestation.
P2860
Q24553312-0602F12F-1C40-471D-98FE-84C3A1F99041Q26741093-AA49D795-36A5-4D31-A7C3-EFFF82C6152CQ26744192-618EF4A8-242E-43A4-8461-0CD40FD88065Q26771172-5DE97C61-7D9F-44DA-A014-22ACF0C16A82Q30436805-FDAF0B6C-80C3-45B1-9E53-088796D36B3AQ30693052-6B4C1FED-C9F8-4AF6-938D-10F9BD296EACQ30867263-EADAAF62-8A31-4526-BB0D-D13E497F5129Q30982488-6247D6A2-F7C7-4FB8-8A56-DE0773696D7FQ33526184-46962F5B-1B2D-43B4-ADF2-E7E4E4C568E1Q33610679-B7E3BE76-594E-445E-8302-94D1119BDEF1Q33670687-0B704674-1297-473B-B873-AB865299AE5EQ33907444-1207C304-2576-4683-83A9-E65B4C957B0BQ33938395-66126B68-E198-4571-82CD-D2B88826C5EAQ34107759-EE84DAD7-65A4-48AE-A3D8-DD18863ECF45Q34248479-75E227F4-7CA8-4F98-8EEF-050FDB909603Q34260031-E8BFDA3B-E6E8-4750-8557-BAEF3A88E798Q34275916-7BD158E8-33EE-4952-ABF2-DACEE2D0B248Q34307867-FF5634A0-3F94-41C5-A287-DAC546C30280Q34433896-C6877E10-0CAE-4418-A843-5265E5B4878FQ34449512-718A22D9-DDD9-414B-B72B-AE1FCDFED652Q34538928-5930B524-556F-4817-8803-9714C9639408Q34549626-7DB28A49-43A5-4C95-8527-2F8F0E9FFC67Q34564758-FC52ACE4-CDFC-476D-B3C2-DAE2D207905FQ34570889-5E82DEBB-3083-4D5C-9E7D-86EA77FAFE64Q34606923-815C57B6-E5AB-4855-9A3F-505C46A89F83Q34700152-D3CE24A8-6E97-4DF1-958C-8363CA46061FQ34782796-FAD47237-92C5-4268-922E-8080C57757D2Q34983634-047D6A1B-DF06-414C-8FFA-E191D411B8F1Q35200431-849CAF71-759F-4906-938A-1CF31552A0CAQ35458222-DF4F753D-499B-4572-B25B-E0E5C1EFD708Q35556651-F4A1F537-2F65-40DF-B6AF-18722191C72FQ35561316-6A4EA799-4BA5-4167-9362-DA666199AF7BQ35658585-5D9493FA-D5C9-4904-8454-70EAF39370D2Q35882453-5E2D457D-538A-4AA3-968A-0DFD7E8199CFQ36258947-4F5EE57F-5B83-487A-81D4-F5CDB1145517Q36616057-70DAF77D-9850-4A32-8F70-7732C2400939Q36654536-A35C75F6-E6EF-4597-B3C3-466879FEE4B6Q36714235-BB129E59-9F22-41E1-98C3-1D5B0A98AFE4Q36997178-E2E43A5C-73D2-4382-837D-F20C01F0AD2FQ37001520-DDC10E97-990B-483C-8560-F407A7248125
P2860
Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma.
description
1973 nî lūn-bûn
@nan
1973 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1973 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1973年の論文
@ja
1973年論文
@yue
1973年論文
@zh-hant
1973年論文
@zh-hk
1973年論文
@zh-mo
1973年論文
@zh-tw
1973年论文
@wuu
name
Development and clinical appli ...... e vasopressin in human plasma.
@ast
Development and clinical appli ...... e vasopressin in human plasma.
@en
Development and clinical appli ...... e vasopressin in human plasma.
@nl
type
label
Development and clinical appli ...... e vasopressin in human plasma.
@ast
Development and clinical appli ...... e vasopressin in human plasma.
@en
Development and clinical appli ...... e vasopressin in human plasma.
@nl
prefLabel
Development and clinical appli ...... e vasopressin in human plasma.
@ast
Development and clinical appli ...... e vasopressin in human plasma.
@en
Development and clinical appli ...... e vasopressin in human plasma.
@nl
P2093
P2860
P356
P1476
Development and clinical appli ...... e vasopressin in human plasma.
@en
P2093
P2860
P304
P356
10.1172/JCI107423
P407
P577
1973-09-01T00:00:00Z